drugset / Trial / NCT00568464
Study on VCD/IE in the Patients With Ewing's Sarcoma Family of Tumors (ESFT)
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this clinical trial was to evaluate the efficacy and tolerability of the sequential therapy of VCD/IE in the patients with ESFT.
Timeline
- Start
- 2007-03
- Primary completion
- 2009-05
- Completion
- 2009-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ADM | Unknown | 75 mg/m2 | — |
| Subject | CTX | Unknown | 1200 mg/m2 | — |
| Subject | Etoposide | Small molecule | 100 mg/m2 | — |
| Subject | IFO | Unknown | 1800 mg/m2 | — |
| Subject | VCR | Unknown | 2 mg | — |
| Background | 2-MERCAPTOETHANESULFONIC ACID | Small molecule | 240 mg/m2 | — |
| Background | 2-MERCAPTOETHANESULFONIC ACID | Small molecule | 360 mg/m2 | — |
| Background | G-CSF | Unknown | 300 ug | — |